Bluejay Diagnostics (BJDX) Retained Earnings (2020 - 2026)

Bluejay Diagnostics (BJDX) has 7 years of Retained Earnings data on file, last reported at -$43.4 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 18.9% year-over-year to -$43.4 million; the trailing twelve-month figure through Mar 2026 stood at -$43.4 million (down 18.9% YoY), and the FY2025 full-year result was -$41.5 million, down 19.75% from the prior year.
• Retained Earnings slipped to -$43.4 million in Q1 2026, from -$41.5 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $28.7 million in Q1 2023 to a low of -$43.4 million in Q1 2026.
• A 5-year average of -$22.8 million and a median of -$29.3 million in 2024 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings slumped 383.58% in 2022 and soared 395.45% in 2023, its largest moves.
• Tracing BJDX's Retained Earnings over 5 years: stood at -$17.0 million in 2022, then tumbled by 58.56% to -$27.0 million in 2023, then decreased by 28.64% to -$34.7 million in 2024, then slipped by 19.75% to -$41.5 million in 2025, then declined by 4.62% to -$43.4 million in 2026.
• Business Quant data shows BJDX's Retained Earnings at -$43.4 million in Q1 2026, -$41.5 million in Q4 2025, and -$40.1 million in Q3 2025.